Wu Jutong News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Source：
2021-04-15 17:26
Shijiazhuang Yiling Pharmaceutical, which produces Lianhua Qingwen, a commonly available over-the-counter medicine in China, has seen its sales skyrocket after the traditional Chinese medicine proved effective in the treatment of symptoms related to COVID-19.
The company s revenue grew 50 percent year-on-year in 2020 on the back of surging Lianhua Qingwen sales. Net profit hit 1.22 billion yuan ($184.3 million) last year, up some 101 percent year-on-year, the company said.
TCM has been recognized by many countries worldwide as effective in alleviating some symptoms related to the novel coronavirus, but faces challenges in being exported to markets outside China, according to the company. ....

United States , South Korea , Lianhua Qingwen , Wu Jutong , Zhang Zhongjing , Second Military Medical University , Yiling Medical Research Institute , National Health Commission , Technology Progress , Leiden University , Cardiff University , National Science , School Of Pharmaceutical Sciences Xiamen University , Tianjin University Of Traditional Chinese Medicine , Shijiazhuang Yiling Pharmaceutical , Maxing Shigan Decoction , Han Dynasty , Yinqiao Powder , Qing Dynasty , State Key Laboratory , Respiratory Disease , Guangzhou Medical University , Tianjin University , Traditional Chinese Medicine , Beijing Hospital , Pharmaceutical Sciences Xiamen University ,